Altered Biodistribution and Incidental Findings on Myocardial Perfusion Imaging

Seminars in Nuclear Medicine

Volumn 40, Issue 4, 2010, Pages 257-270

  Chamarthy, Murthy ^a   Travin, Mark I ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM; RADIOPHARMACEUTICAL AGENT;

ANGINA PECTORIS; ARTIFACT; BENIGN TUMOR; DEXTROCARDIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE RECONSTRUCTION; INCIDENTAL FINDING; LUNG EMBOLISM; LUNG SARCOIDOSIS; MALIGNANT NEOPLASTIC DISEASE; MYOCARDIAL PERFUSION IMAGING; PARATHYROID ADENOMA; PROGNOSIS; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC USE; METABOLISM; PROCEDURES; TISSUE DISTRIBUTION;

ARTIFACTS; CARDIOVASCULAR DISEASES; HUMANS; INCIDENTAL FINDINGS; MYOCARDIAL PERFUSION IMAGING; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 77952691882     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2010.03.005     Document Type: Review

References (85)

1. Klocke F.J., Baird M.G., Bateman T.M., et al. ACC:/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Radionuclide Imaging). J Am Coll Cardiol 42 (2003) 1318-1333
2. Shaw L.J., and Iskandrian A.E. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 11 (2004) 171-185
3. Lee T.H., and Udelson J.E. Nuclear cardiology: Guidelines. In: Libby P., Bonow R.O., Mann D.L., Zipes D.P., and Braunwald E. (Eds). Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. (ed 8) (2008), W. B. Saunders, Philadelphia
4. Hachamovitch R., Hayes S.W., Friedman J.D., et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107 (2003) 2900-2906
5. Hendel R.C., Gibbons R.J., and Bateman T.M. Use of rotating (cine) planar images in the interpretation of a tomographic myocardial perfusion study. J Nucl Cardiol 6 (1999) 234-240
6. Rehm P.K., Atkins F.B., Ziessman H.A., et al. Frequency of extra-cardiac activity and its effect on Tc99m-MIBI cardiac SPET interpretation. Nucl Med Commun 17 (1996) 851-856
7. Williams K.A., Hill K.A., and Sheridan C.M. Noncardiac findings on dual-isotope myocardial perfusion SPECT. J Nucl Cardiol 10 (2003) 395-402
8. Raza M., Panjrath G.S., Haider A., et al. Extracardiac abnormalities on myocardial perfusion imaging. J Nucl Cardiol 12 (2005) S36 (abstr)
9. Gedik G.K., Ergun E.L., Aslan M., et al. Unusual extracardiac findings detected on myocardial perfusion single photon emission computed tomography studies with Tc-99m sestamibi. Clin Nucl Med 32 (2007) 920-926
10. Aktolun C., Bayhan H., and Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201. Clin Nucl Med 17 (1992) 171-176
11. Aktolun C., Bayhan H., Pabuccu Y., et al. Assessment of tumor necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m sestamibi imaging: Comparison with CT scan. Eur J Nucl Med 21 (1994) 973-979
12. Hindie E., Melliere D., Perlemuter L., et al. Primary hyperparathyroidism: Higher success rate of first surgery after preoperative Tc-99m sestamibi-I-123 subtraction scanning. Radiology 204 (1997) 221-228
13. Van Kriekinge S.D., Germano G., Forscher C., et al. Tumor quantitation and monitoring in whole-body planar technetium-99msestamibi imaging. J Nucl Med 38 (1997) 356-361
14. Kinuya S., Yokoyama K., Watanabe N., et al. Early response of tumour to radiotherapy should be assessed by both uptake and retention of single photon tracers: In vitro analysis with 201Tlchloride, 99Tcm-sestamibi and 99Tcm-tetrofosmin in human bladder cancer cells and human leukocytes. Nucl Med Commun 20 (1999) 581-588
15. Maffioli L., Steens J., Pauwels E., et al. Applications of 99m Tc-sestamibi in oncology. Tumori 82 (1996) 12-21
16. Piwnica-Worms D., and Holman B.L. Noncardiac applications of hexakis-(alkylisonitrile) technetium-99m complexes. J Nucl Med 31 (1990) 1166-1167
17. Fenlon H.M., Phelan N.C., O'Sullivan P., et al. Benign versus malignant breast disease: Comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography. Radiology 205 (1997) 214-220
18. Caner B., Kitapci M., Unlu M., et al. Technetium-99m-MIBI uptake in benign and malignant bone lesions: A comparative study with technetium-99m-MDP. J Nucl Med 33 (1992) 319-324
19. Fukushima K., Kono M., Ishii K., et al. Technetium-99m methoxyisobutylisonitrile single-photon emission tomography in hepatocellular carcinoma. Eur J Nucl Med 24 (1997) 1426-1428
20. Chatziioannou S.N., Alfaro-Franco C., Moore W.H., et al. The significance of incidental noncardiac findings in Tc-99m sestamibi myocardial perfusion imaging: Illustrated by a case (1999), Tex Heart Inst J 26:229-231
21. Klain M., Maurea S., Lastoria S., et al. Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer. J Nucl Med 36 (1995) 2248-2251
22. Lind P., Gallowitsch H.J., Langsteger W., et al. Technetium-99m tetrofosmin whole body scintigraphy in the follow-up differentiated thyroid carcinoma. J Nucl Med 38 (1997) 348-352
23. Seabold J.E., Gurll N., Schurrer M.E., et al. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy. J Nucl Med 40 (1999) 1434-1440
24. Sundram F.X., and Mack P. Evaluation of thyroid nodules for malignancy using 99Tcm-sestamibi. Nucl Med Commun 16 (1995) 687-693
25. Alonso O., Lago G., Mut F., et al. Thyroid imaging with Tc-99m MIBI in patients with solitary cold single nodules on pertechnetate imaging. Clin Nucl Med 21 (1996) 363-367
26. Watanabe N., Hirano T., Fukushima Y., et al. Esophageal cancer detection with Tc-99m tetrofosmin SPECT. Clin Nucl Med 22 (1997) 431-433
27. Ziegels P., Nocaudie M., Huglo D., et al. Comparison of technetium-99m-methoxy-isobutylisonitrile and gallium-67-citrate scanning in assessment of lymphomas. Eur J Nucl Med 22 (1995) 126-131
28. Abdel-Dayem H.M., Naddaf S.Y., Omar W.S., et al. Delayed positive thallium uptake in large B-cell non-Hodgkin's malignant lymphoma. J Nucl Med 38 (1997) 1213-1215
29. Matsui R., Komori T., Narabayashi I., et al. Tc-99m sestamibi uptake by malignant lymphoma and slow washout. Clin Nucl Med 20 (1995) 352-356
30. Soderlund V., Jonsson C., Bauer H.C., et al. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas. J Nucl Med 38 (1997) 682-686
31. Ramanna L., Waxman A., Binney G., et al. Thallium-201 scintigraphy in bone sarcoma: Comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 31 (1990) 567-572
32. Kunisada T., Ozaki T., Kawai A., et al. Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: Angiography compared with thallium-201 scintigraphy. Cancer 86 (1999) 949-956
33. Valdes Olmos R.A., Koops W., Loftus B.M., et al. Correlative 201Tl SPECT, MRI and ex vivo 201Tl uptake in detecting and characterizing cervical lymphadenopathy in head and neck squamous cell carcinoma. J Nucl Med 40 (1999) 1414-1419
34. Yigitbasi O.G., Tutus A., Bozdemir K., et al. 201Tl imaging for differentiating between malignant and benign neck masses. Nucl Med Commun 19 (1998) 555-560
35. Henzlova M.J., Cerqueira M.D., Hansen C.L., et al. ASNC imaging guidelines for nuclear cardiology procedures: Stress protocols and tracers (2009), J Nucl Cardiol 16
36. Athar H., and Heller G. Basic principles of flow tracers. In: Heller G.V., Mann A., and Hendel R.C. (Eds). Nuclear Cardiology: Technical Applications (2008), McGraw-Hill, New York
37. Beller G.A., and Bergmann S.R. Myocardial perfusion imaging agents: SPECT and PET. J Nucl Cardiol 11 (2004) 71-86
38. Jain D. Technetium-99m labeled myocardial perfusion imaging agents. Semin Nucl Med 29 (1999) 221-236
39. Chin B.B., Zukerberg B.W., Buchpiguel C., et al. Thallium-201 uptake in lung cancer. J Nucl Med 36 (1995) 1514-1510
40. 201T1 uptake, nuclear DNA content and clinical behavior in metastatic thyroid carcinoma. J Nucl Med 40 (1999) 963-967
41. Piwnica-Worms D.P., Kronauge J.F., LeFurgey A., et al. Mitochondrial localization and characterization of 99Tc-sestamibi in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy. Magn Reson Imaging 12 (1994) 641-652
42. Mansi L., Rambaldi P.F., Cuccurullo V., et al. Diagnostic and prognostic role of 99m-Tc-tetrofosmin in breast cancer. Q J Nucl Med 41 (1997) 239-250
43. Fiskum G (ed): Mitochondrial Physiology and Pathology. New York, Van Nostrand Reinhold, 1986
44. Heller G.V. Tracer selection with different stress modalities based on tracer kinetics. J Nucl Cardiol 3 suppl 6 (1996) S15-S21
45. Coakley A.J., Kettle A.G., Wells C.P., et al. 99mTcsestamibi: A new agent for parathyroid imaging. Nucl Med Commun 10 (1989) 791-794
46. O'Doherty M.J., Kettle A.G., Wells P., et al. Parathyroid imaging with technetium-99m-sestamibi: Preoperative localization and tissue uptake studies. J Nucl Med 33 (1992) 313-318
47. Taillefer R., Roidoux A., Lambert R., et al. Technetium-99m sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 36 (1995) 1758-1765
48. Waxman A.D. The role of (99m)Tc methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med 27 (1997) 40-54
49. Lee V.W., Antonacci V., Tilak S., et al. Intracranial mass lesions: Sequential thallium and gallium scintigraphy in patients with AIDS. Radiology 211 (1999) 507-512
50. Taillefer R., Robidoux A., Turpin S., et al. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer. J Nucl Med 39 (1998) 459-464
51. Taillefer R. The role of 99mTc sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med 29 (1999) 16-40
52. Scopinaro F., Schillaci O., Scarpini M., et al. Technetium-99m sestamibi: An indicator of breast cancer invasiveness. Eur J Nucl Med 21 (1994) 984-987
53. Waxman A.D. The role of 99mTc methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med 27 (1997) 40-54
54. Khalkhali I., Cutrone J., Mena I., et al. Technetium-99m-sestamibi scintimammography of breast lesions: Clinical and pathological follow-up. J Nucl Med 36 (1995) 1784-1789
55. Lind P., Umschaden H.W., Forsthuber E., et al. Scintimammography using Tc-99m tetrofosmin. Acta Med Austriaca 24 (1997) 50-54
56. Bongers V., Borel Rinkes I.H., Sie-Go D.M., et al. Detection of malignant breast tumours in dense breast tissue: Results of 99mTctetrofosmin scintimammography related to surgery. Eur J Surg Oncol 25 (1999) 152-156
57. Bom H.S., Kim Y.C., Song H.C., et al. Technetium-99m-MIBI uptake in small cell lung cancer. J Nucl Med 39 (1998) 91-94
58. Nishiyama Y., Kawasaki Y., Yamamoto Y., et al. Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer. J Nucl Med 38 (1997) 1358-1361
59. Suga K., Kume N., Nishigauchi K., et al. 201Tl SPECT as an indicator for early prediction of therapeutic effects in patients with non-small cell lung cancer. Ann Nucl Med 12 (1998) 355-362
60. Takekawa H., Shinano H., Tsukamoto E., et al. Technetium-99m tetrofosmin imaging of lung cancer: Relationship with histopathology. Ann Nucl Med 13 (1999) 71-75
61. Kao C.H., Ho Y.J., Shen Y.Y., et al. Evaluation of chemotherapy response in patients with small cell lung cancer using technetium-99m-tetrofosmin. Anticancer Res 19 (1999) 2311-2315
62. Kashitani N., Eda R., Masayoshi T., et al. Lobar extent of pulmonary lymphangitic carcinomatosis. Tl-201 chloride and Tc-99m MIBI scintigraphic findings. Clin Nucl Med 21 (1996) 726-729
63. Aktolun C., Demirel D., Kir M., et al. Technetium-99m-MIBI and thallium-201 uptake in pulmonary actinomycosis. J Nucl Med 32 (1991) 1429-1431
64. Onsel C., Sonmezoglu K., Camsari G., et al. Technetium-99m-MIBI scintigraphy in pulmonary tuberculosis. J Nucl Med 37 (1996) 233-238
65. Lamont A.E., Joyce J.M., and Grossman S.J. Acute cholecystitis detected on a Tc-99m sestamibi myocardial imaging. Clin Nucl Med 21 (1996) 879
66. Iagaru A., Hachamovitch R., Colletti P.M., et al. Demonstration of an ectopic mediastinal parathyroid adenoma on Tc-99m sestamibi myocardial perfusion scintigraphy. J Nucl Cardiol 13 (2006) 719-721
67. Pusuwan P., Ratanamart V., Suwanagool P., et al. Ectopic parathyroid imaging With Tc-99m sestamibi. Clin Nucl Med 21 (1996) 74
68. Garcia de la Torre N., Wass J.A., and Turner H.E. Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer 10 (2003) 309-322
69. Slavin J.D., Engin I.O., and Spencer R.P. Retrocardiac uptake of Tc-99m sestamibi: Manifestation of a hiatal hernia. Clin Nucl Med 23 (1998) 239-240
70. Ghanbarinia A., Chandra S., Chhabra K., et al. Renal abnormalities as incidental findings on myocardial single photon emission computed tomography perfusion imaging. Nucl Med Commun 29 (2008) 588-592
71. Raza M., Meesala M., Panjrath G., et al. Abnormal photopenic area on nuclear perfusion imaging. J Nucl Cardiol 12 (2005) 607-609
72. Hurwitz G.A., Duan H.Y., Blais M., et al. An atlas of renography with Tc-99m sestamibi: Comparison with Tc-99m DTPA. Clin Nucl Med 20 (1995) 821-829
73. DePuey E.G., and Garcia E.V. Optimal specificity of thallium-201 SPECT through recognition of imaging artifacts. J Nucl Med 30 (1989) 441-449
74. Cullom S.J. Artifacts and quality control for myocardial perfusion SPECT including attenuation correction. In: Heller G.V., Mann A., and Hendel R.C. (Eds). Nuclear Cardiology: Technical Applications (2008), McGraw-Hill, New York
75. Germano G., Chua T., Kiat H., et al. A quantitative phantom analysis of artifacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies. J Nucl Med 35 (1994) 356-359
76. Folks R. Myocardial SPECT processing. In: Heller G.V., Mann A., and Hendel R.C. (Eds). Nuclear Cardiology: Technical Applications (2008), McGraw-Hill, New York
77. Ibrahim D.Y., DiFilippo F.P., Steed J.E., et al. Optimal SPECT processing and display: Making bad studies look good to get the right answer. J Nucl Cardiol 13 (2006) 855-866
78. Williams K.A., and Schneider C.M. Increased stress right ventricular activity on dual isotope perfusion SPECT. A sign of multivessel and/or left main coronary artery disease. J Am Coll Cardiol 34 (1999) 420-427
79. Pereira N., Klutz W., Fox R., et al. Identification of severe right ventricular dysfunction by technetium-99m-sestamibi gated SPECT imaging. J Nucl Med 38 (1997) 254-256
80. McConnell M.V., Solomon S.D., Rayan M.E., et al. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 78 (1996) 469-473
81. Hansen C.L., Goldstein R.A., Akinboboye O.O., et al. Myocardial perfusion and function: Single photon emission computed tomography. J Nucl Cardiol 14 (2007) e39-e60
82. Van Kiat H., Train K.F., Freidman J.D., et al. Quantitative stress-redistribution thallium-201 SPECT using prone imaging. Methodological development and validation. J Nucl Med 33 (1992) 1509-1515
83. Segall G., and Davis M. Prone versus supine thallium myocardial SPECT: A method to decrease artifactual inferior wall defects. J Nucl Med 30 (1989) 548-555
84. Pitman A.G., Kalff V., Van Every B., et al. Contributions of subdiaphragmatic activity, attenuation, and diaphragmatic motion to inferior wall artifact in attenuation-corrected Tc-99m myocardial perfusion SPECT. J Nucl Cardiol 12 (2005) 401-409
85. Bateman T.M., and Cullom S.J. Attenuation correction single-photon emission computed tomography myocardial perfusion imaging. Semin Nucl Med 35 (2005) 37-51